Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

BIOC

Biocept (BIOC)

Biocept Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BIOC
일자시간출처헤드라인심볼기업
2023/10/2019:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOCBiocept Inc
2023/10/1621:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOCBiocept Inc
2023/09/2121:00Business WireEnrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal MetastasesNASDAQ:BIOCBiocept Inc
2023/09/0821:00Business WireBiocept Signs CNSide™ Licensing Agreement with Plus TherapeuticsNASDAQ:BIOCBiocept Inc
2023/09/0521:00Business WireBiocept to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:BIOCBiocept Inc
2023/08/2521:00Business WireBiocept to Hold Business Update Conference Call on August 30, 2023NASDAQ:BIOCBiocept Inc
2023/08/2305:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOCBiocept Inc
2023/08/1505:05Business WireBiocept Reports Second Quarter 2023 Financial ResultsNASDAQ:BIOCBiocept Inc
2023/08/1421:00Business WireBiocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer ConferenceNASDAQ:BIOCBiocept Inc
2023/07/1407:15Business WireBiocept Announces the Passing of Board Chair M. Faye WilsonNASDAQ:BIOCBiocept Inc
2023/06/2205:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOCBiocept Inc
2023/06/2108:10Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BIOCBiocept Inc
2023/06/2105:15Business WireBiocept Names Antonino Morales as President and Chief Executive OfficerNASDAQ:BIOCBiocept Inc
2023/06/1505:05Business WireBiocept to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20, 2023NASDAQ:BIOCBiocept Inc
2023/06/0521:00Business WireScientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept’s CNSide™ Versus CytologyNASDAQ:BIOCBiocept Inc
2023/05/2519:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BIOCBiocept Inc
2023/05/2509:39Business WireBiocept Announces Pricing of $5.0 Million Underwritten Public OfferingNASDAQ:BIOCBiocept Inc
2023/05/2321:18Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:BIOCBiocept Inc
2023/05/1721:00Business WireBiocept Announces One-for-Thirty Reverse Stock SplitNASDAQ:BIOCBiocept Inc
2023/05/1705:12Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:BIOCBiocept Inc
2023/05/1520:01Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:BIOCBiocept Inc
2023/05/1519:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOCBiocept Inc
2023/05/1105:05Business WireBiocept Reports First Quarter 2023 Financial ResultsNASDAQ:BIOCBiocept Inc
2023/04/2121:31Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:BIOCBiocept Inc
2023/04/2105:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOCBiocept Inc
2023/04/1805:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOCBiocept Inc
2023/04/1805:10Business WireBiocept Reports 2022 Financial ResultsNASDAQ:BIOCBiocept Inc
2023/04/1805:04Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:BIOCBiocept Inc
2023/04/1721:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOCBiocept Inc
2023/04/1105:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOCBiocept Inc
 검색 관련기사 보기:NASDAQ:BIOC